The health industry is highly value-added, compared to other industries. The reason is that increase of income growth and the expanded human life expectancy bring about positively needs of products at health industry. This is related with increase in expenses of health care and R&D investment of health industry. After 1995, the share of GDP at drug & biomedical industry is increased. Especially, the share of GDP at biomedical is 0.12% in 1995 1st quarter, but 0.17% in 2002 3rd quarter, 0.24% in 2008. Biomedical's contribution about GDP growth is to jump into 6.01% in 2008. The share of GDP at drug will continuously expand, compared to other manufacture industries. Also, drug's contribution about GDP growth will increase, compared with before. Conclusionally, total shares of GDP at drug St biomedical industry are to increase, compared with before. Also, this health industry's contribution is to expand as value-added industry and increase of sales.

Abstract
 1. 서론
 2. 국민 의료비의 증가
 3. 노인인구 비중의 빠른 증가
 4. 보건의료 부문의 R&D투자 증가
  4.1. 의약품
  4.2. 의료기기
 5. 보건산업 비중변화 및 기여도 분석
  5.1. VAR모형의 개관
  5.2. 추정결과
 6. 요약 및 결론
 7. 참고문헌

• 김종권